biOasis Technologies Inc BIOAF:OTCQB

Last Price$0.23NASDAQ Previous Close - as of 2:24PM ET 12/02/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.22 (2,500)
Ask (Size)$0.23 (5,000)
Day Low / HighN/A - N/A
Volume1.4 K
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionbiOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in Guilford, CT. View company web site for more details
Address14 Water Street
Guilford, Connecticut 06437
Phone+1.203.533.7082
Number of EmployeesN/A
Recent SEC Filing07/26/2021D
Executive Chairman, President & CEODeborah A. Rathjen
Chief Operating OfficerCaroline Dircks
Chief Financial OfficerDave Jenkins
Vice President & Head-External ResearchMei Mei Tian

Company Highlights

Price Open$0.22
Previous Close$0.23
52 Week Range$0.18 - 0.55
Market Capitalization$16.5 M
Shares Outstanding72.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement01/26/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.02
Beta vs. S&P 500N/A
Revenue$1.1 M
Net Profit MarginN/A
Return on Equity-1,321.67%

Analyst Ratings as of 04/16/2014

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset